Company Overview of BTIG, LLC
BTIG, LLC provides institutional brokerage and fund services. The company specializes in global trading and fund services for hedge funds, mutual funds, separate accounts, and family offices. It operates in various areas, including equity trading, fixed income, futures trading, convertible securities, equity derivatives, prime brokerage, outsource trading, direct market access, capital markets, equity research, and corporate access, as well as international trading, outsource trading, commission management services, portfolio analytics, and market intelligence. In addition, the company provides trading solutions to investment managers. It serves institutional clients worldwide. The company w...
600 Montgomery Street
San Francisco, CA 94111
Founded in 2002
Key Executives for BTIG, LLC
Co-Founder and Chief Executive Officer
Co-Founder and Managing Partner
Chief Financial Officer and Managing Director
Chief Operating Officer, Managing Director and Head of FICC
Compensation as of Fiscal Year 2016.
BTIG, LLC Key Developments
Andre Suaid Joins BTIG, LLC as Managing Director Within its International Equities Group in New York
Jul 18 16
BTIG, LLC announced that Andre Suaid has joined the firm as a Managing Director within its International Equities Group in New York. Mr. Suaid will focus on U.S. and Latin American-based institutional clients, navigating developed, emerging and frontier markets throughout Latin America. He joins an established, global team of professionals throughout BTIG’s nine U.S. offices, and affiliate office locations in London, Edinburgh, Hong Kong, Singapore and Sydney. The move comes in response to increasing client demand and heightened focus in the region. Previously, Mr. Suaid was Head of Latin America Global Prime Finance and Head of International Equity Trading for the Americas at Deutsche Bank Securities. He was responsible for the execution of Deutsche Bank's international products for global clients, overseeing the risk for Latin America Cash, Delta One, and Program and Synthetic Trading. Mr. Suaid was also part of the leadership team responsible for building out the Latin America Synthetic Platform at Deutsche Bank.
BTIG, LLC Announces Management Appointments
Jul 11 16
BTIG, LLC announced that James Sullivan, Michael Gorman, and Tom Catherwood, will join the firm to provide Real Estate Investment Trust (REIT) research coverage. Mr. Sullivan joins BTIG as a managing director, covering all property types. Most recently, he was a managing director and REIT Analyst at Cowen, where he served for the past seven years. Mr. Sullivan held a similar role at Prudential for over a decade. Earlier in his career, he was the chief executive officer for U.S. affiliates of the diversified Korean manufacturer Jindo. Mr. Sullivan was also a Co-Founder and the chief executive officer of Textainer. He began his career as an attorney with Crane and Hawkins in London, specializing in international tax and exchange control regulations. Mr. Gorman joins BTIG as a managing director, covering the healthcare, triple net, strip center and regional mall subsectors. Most recently, he was a director and REIT Analyst at Cowen. Previously, Mr. Gorman held similar roles at Janney Montgomery Scott, Credit Suisse and Prudential. He began his career as an Equity Analyst at Value Line. Mr. Catherwood joins BTIG as a director, covering the office and industrial subsectors. Most recently, he was a vice president and REIT Analyst at Cowen. Previously, Mr. Catherwood was an Associate within the Real Estate Strategy Group, and a project manager and chief of staff within the Real Estate and General Services Group at the Federal Reserve Bank of New York. He began his career as a project manager and construction estimator at Grunley Construction.
BTIG Appoints Ling Wang as Director and Biotechnology Research Analyst in New York
May 23 16
BTIG, LLC announced that Ling Wang, CFA has joined the firm as a Director and Biotechnology Research Analyst in New York. Ms. Wang has more than 15 years of experience in biotechnology research, having analyzed companies within the sector for several global financial services firms in a variety of roles. Most recently, she was a Senior Research Analyst at Oppenheimer & Co. Earlier in her career, she conducted research at Memorial Sloan-Kettering Cancer Center, participating in clinical trials as part of a team that evaluated cancer vaccines. At BTIG, Ms. Wang's coverage will focus on biotechnology companies, industry trends and the competitive landscape.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|